| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,125 |
2,961 |
$210K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,169 |
3,872 |
$161K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,167 |
3,834 |
$143K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,059 |
973 |
$53K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
568 |
529 |
$50K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,003 |
1,395 |
$40K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,380 |
1,276 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
919 |
890 |
$14K |
| 86318 |
|
747 |
700 |
$12K |
| 99201 |
|
233 |
228 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
145 |
125 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$651.17 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
12 |
$455.18 |